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Abstract 
Ingestion of food with high glycaemic index is known to stress the insulin release mechanism that can produce 
Insulin resistance and eventually Diabetes Mellitus. How fast the end product of digestion of carbohydrate 
glucose surges into the bloodstream and the peak level attained are equally important for the glucose control 
mechanism of the body and ultimately the health of the individual involved. This study aims at exploring the 
effect of Moringa oleifera seed on the post-prandial rate of absorption of glucose and the peak glucose level 
attainable. Five healthy young male adult (18-35) volunteers had their Oral Glucose Tolerance Test (OGTT) 
conducted the first day as a control group followed the next day by a second OGTT with a pre-treatment with 
Moringa oleifera seed powder in a fix dose of 0.0175 gram per Kilogram body weight as the test/case group. The 
results indicate that it takes 60 minutes for the blood glucose to reach the peak concentration of 118.6 mg/dl in 
treatment group as against 30 minutes in the control group reaching 135mg/dl optimal concentration. The 
difference in this concentration and rate of surge are significant (p<0.05) A slower rise and a smaller optimal 
concentration of glucose are demonstrated as response to Moringa oleifera powder ingestion, a potentially clear 
beneficial effect. 
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Introduction  
Moringa oleifera is a pantropical tree. It is locally call various names according to the geocultural setting. Such 
names include Horseradish, Benolive, Morongo, Mulangay, Saijhan or sajna, Benoil or Benoil tree (Duke JA, 
1987). Moringa oleifera is a rich source of nutrient and helps in ecological management. It is cheap and grows 
well in various climates. Moringa oleifera is one of the 14 species In the Moringaceae family. They grow fast 
and remarkably resist adverse conditions. The seed of Moringa oleifera is often remove from the mature pod and 
consume like peas or groundnut.  It is rich in ascorbic acid, lots of the B vitamins and mineral. There several 
report on the benefits of the use various parts of Moringa oleifera plant on blood glucose level and thus widely 
held belief that it is useful in the treatment of diabetes mellitus (Mossa, 1985). The seed is of particular 
importance because of its ability in reducing blood glucose level (Makonnen et al, 1997). In Indian traditional 
system of medicine, Moringa oleifera Lam Sayan. Moringa Pteryosperma Gaerth (Moringaceae) is commonly 
used as healing herbs to treat diabetes.  
The phytochemical screening and toxicity studies on the methanol extract of the seeds of Moringa 
oleifera show signs of acute toxicity observed at a dose of 4,000mgkg
-1
 in the acute toxicity test and mortality 
was recorded at 5000mgkg
-1 
(Ajibade et al 2013). No adverse effect was observed at concentration lower than 
3,000mgkg
-1
. The median lethal those of the extract in rat was 3,873mgkg
-1
. Subacute administration of the seed 
extract caused significant (p<0.05) increase in the level of Alanine and aspartate transferases (ALT and AST), 
and significant (p<0.05) decrease in weight of experimental rats, at 1600mgkg
-1
. The study concludes that the 
extract of seeds Moringa oleifera is safe both for medicinal and nutritional uses.  
Insulin resistance and relative deficiency in insulin secretion are the major pathophysiological features 
of impaired glucose tolerance and type-2 diabetes (Simonson, 2015). Although the euglycaemic-
hyperinsulinaemic clamp and the hyperglycaemic clamp are the 'gold standards', respectively, for measuring 
these metabolic defects, there has been an active search during the past few decades for simpler and less 
expensive surrogate measures of insulin resistance that can be applied more globally in epidemiological studies 
or large clinical trials. These surrogate markers primarily rely on plasma insulin and glucose levels measured 
either in the fasting state or after an oral glucose challenge. Although many of these surrogate measures correlate 
well with the clamp (with r values frequently as high as 0.60-0.70) within racially and ethnically homogeneous 
populations, it is not clear how well they can be used to compare insulin action across different groups. 
The surge in blood Glucose level following ingestion of carbohydrate rich meal is important at two 
levels. First it is the speed with which the glucose is absorbed into the bloodstream and secondly the peak 
concentration of glucose that is attained.  The rapid surge in blood glucose level stress the insulin release leading 
hyperinsulinaemia, and abnormally high lipids concentration in blood, eventually insulin resistance and higher 
level of glucose may result and that produce symptoms and signs similar to what is obtainable in full blown 
diabetes mellitus. Any food material capable of reducing the rapid surge in blood glucose may be viewed 
beneficial in management of diabetes mellitus. The reduction in the postprandial peak level of glucose is also of 
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importance. Abnormally high level of lipids that may follow high level of Insulin concentration in the blood is 
also a risk factor in the pathogenesis of cardiovascular diseases (Mehta et al, 2003 
 
Materials and Methods 
The seed of the Moringa oleifera is de-shelled and powdered and dry weight  measured. Estimated dose usually 
consume by individuals in this environment (four average sized seeds) is match against safety range from results 
of toxicology studies to validate the safe and suitable dose for administration in this study test group. The test 
group is six healthy young male adult volunteers. 
Oral Glucose Tolerance Test (OGTT) series are conducted as a control in the first day, and the next day 
a second OGTT series are performed on the same individuals, now as test group that ingest powder Moringa 
oleifera seed powder in the same dose according to their body sizes. 
 
Inclusion criteria 
The subjects were young male adults with normal body mass indices (BMI) and who had no history of any 
endocrine metabolic disease or recent febrile illness. They also had no previous history of reaction to Moringa 
oleifera seeds. 
 
Exclusion Criteria 
Presence of Diabetes mellitus or glycogen storage disease, febrile illness or any major disorder was excluded. 
The subjects were not also taking any medications. 
 
Methodology 
After obtaining ethical clearance from the University of Jos ethical committee, five young male adults were 
chosen for the study. The subjects were instructed to fast overnight (not to eat or drink water for at least 12 
hours). The weight of each subject was recorded first. The fasting blood sugar levels were evaluated on the blood 
taken by finger tip pricking. The finger was properly disinfected using a chorhexidine-swab, allowed to dry and 
then pricked carefully to avoid piercing the underlying artery. A drop of blood from the finger was then placed 
on the indicator on the Glucometer strip. When the coding clip was properly fixed into the glucose meter, the 
strip is fixed as the indicator light flashes. The result is displayed on the screen within 3-5 seconds. 0.0175g/kg 
body weight of each subject of glucose D solution was given to the subjects. The blood glucose level of each 
subject was recorded at 0 min, 20 min, 1 hour, 1.5 hours, 2 hours, 2.5 hours and 3 hours seven sample in all.  
The next day, fasting blood sugar of each subject was taken again to obtain a baseline. Each subject is 
given 5 seeds of Moringa oleifera (each seed has an average weight of 0.3g) to chew and a little water to wash it 
down after chewing. Five minutes later, glucose solution was given to them to drink according to their individual 
body weights. Blood glucose level is repeated at 30, 60, 90, 120, 150 and 180 minutes and recorded accordingly. 
The mean of these values was calculated and the graph of mean (mmol/L) was plotted against time (hours).  
 
Day 1  
The first day was for control evaluation. Each subject was given glucose D solution only and OGTT performed.  
 
Day 2  
The second day was a test for with Moringa oleifera. Each subject was given Moringa oleifera seed first then 
after 5 minutes later glucose D solution was administered.  
Combi-2 urinalysis test strips were used to check the urine of each of the subjects. This is to check if urine 
glucose is normal.  
 
Results 
The results of this study are presented on the tables and figures below. 
 
Table 1: Table showing Computation of Moringa oleifera doses for administration to subject volunteers 
Subject No Body weight MO 0.0175g/kg Glucose 2g/kgBWt No. of teaspoon 
1. 79 1.3825 158 11 
2. 63 1.1025 126 8 
3. 72 1.26 144 10 
4. 70 1.225 140 9 
5. 86 1.505 172 12 
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Table 2: Table Showing Glucose Levels Across Periods in the Absence of Treatment/Control 
Time (Minutes) N Mean Std. Deviation Std. Error 
  Blood Glucose mg/dl   
0 5 89.20 11.883 5.314 
30 5 135.00 21.552 9.638 
60 5 114.00 8.216 3.674 
90 5 109.00 12.042 5.385 
120 5 106.40 5.550 2.482 
150 5 92.40 11.803 5.278 
180 5 93.40 12.740 5.697 
Total  35 105.63 19.019 3.215 
 
Table 3: Table showing Comparative values of Glucose levels in OGTT Across Periods without 
Treatment/Control and with Moringa oleifera pre-treatment/Cases/Tests 
Time 
(Minutes ) 
Blood Glucose level in Control Group(mg/dl) 
+ SEM 
Blood glucose Level in Test Group (mg/dl) 
+ SEM 
0 89.2 + 5.31 87.6 + 4.88 
30 135 + 9.63 111.4 + 11.61 
60 114 + 3.67 118.6 + 4.70 
90 109 + 5.38 94 + 4.37 
120 106.4 + 2.48 95.8 + 3.94 
150 92.4 + 5.27 90 + 3.17 
180 93.4 + 5.69 84 + 2.54 
Mean 739.4      680 
 
Table 4: ANOVA  
 Sum of Squares df Mean Square F Sig.  
Between Groups Within Groups Total 7695.771 
4602.400 
12298.171 
6 
28 
34 
1282.629 
164.371 
7.803 0.0001 (0.05) 
 
Table 5: Comparing Oral Glucose Tolerance Test values between cases and controls Descriptive  
 Mean Std. Deviation Std. Error 95% Confidence Interval for Mean Range 
    Lower Bound Upper Bound  
Control  
Case  
Total 
105.63 
97.34 
101.49 
19.019 
16.800 
18.295 
3.215 
2.840 
2.187 
99.10 
91.57 
97.12 
112.16 
103.11 
105.85 
72-162 
71-151 
71-162 
 
Table 6: ANOVA  
 Sum of Squares df Mean Square F P-Value 
Between Groups 
Within Groups 
Total 
1201.429 
21894.057 
23095.486 
1 
68 
69 
1201.429 
321.971 
3.731 0.058(>0.05) 
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Figure 1. Line graph comparing Group means of Glucose levels between cases and controls 
 
Table 7: Comparing Glucose tolerance levels between cases and controls  
Descriptive Statistics 
 Mean Std. Deviation Std. Error 95% Confidence Interval for Mean Range 
    Lower Bound Upper Bound  
Control  
Case  
Total 
105.63 
97.34 
101.49 
19.019 
16.800 
18.295 
3.215 
2.840 
2.187 
99.10 
91.57 
97.12 
112.16 
103.11 
105.85 
72-162 
71-151 
71-162 
 
Table 8: ANOVA  
 Sum of Squares df Mean Square F P-Value 
Between Groups 
Within Groups 
Total 
1201.429 
21894.057 
23095.486 
1 
68 
69 
1201.429 
321.971 
3.731 0.058(>0.05) 
Analysis of Variance was performed to compare the means of glucose tolerance levels across the periods of 
cases without the administration of the seed powder. As observed from the ANOVA test below, there was a 
significant difference across and between the respective period as proven by the probability value (P<0.05)  
 
Table 9: ANOVA  
 Sum of Squares df Mean Square F Sig.  
Between Groups Within Groups Total 7695.771 
4602.400 
12298.171 
6 
28 
34 
1282.629 
164.371 
7.803 0.0001 (0.05) 
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Figure 2: Graph of Mean Glucose Levels in Subjects against Time   
 
Table 10: Comparing Glucose tolerance levels between cases and controls  
Descriptive  
 Mean Std. Deviation Std. Error 95% Confidence Interval for Mean Range 
    Lower Bound Upper Bound  
Control  
Case  
Total 
105.63 
97.34 
101.49 
19.019 
16.800 
18.295 
3.215 
2.840 
2.187 
99.10 
91.57 
97.12 
112.16 
103.11 
105.85 
72-162 
71-151 
71-162 
 
Table 11: ANOVA  
 Sum of Squares df Mean Square F P-Value 
Between Groups 
Within Groups 
Total 
1201.429 
21894.057 
23095.486 
1 
68 
69 
1201.429 
321.971 
3.731 0.058(>0.05) 
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Figure 3: A Line Graph Showing OGTT Curves in Control and Test Subjects 
 
Discussion  
The study shows that Moringa oleifera seed slows the rate of Post-Prandial surge in blood glucose level and the 
peak concentration of blood glucose level attainable. Analysis of variance is performed to compare the mean of 
glucose levels across the time frame of each of the subject cases after the administration of Moringa oleifera 
seed. As observed on the graph, there was a significant difference across between the respective periods as 
proven by a probability value of 0.001 (p<0.05). The results also show that Moringa oleifera slows down the rate 
at which glucose enters the blood as seen within the first 1hour of administration. From the next 2 hours, the 
glucose levels of the control and test show no significance difference. This shows that Moringa oleifera doesn’t 
cause a significant crash in glucose level which could result in hypoglycaemia in the long run even in healthy 
subjects. Moringa oleifera could therefore possibly be used as a supplement in diabetic treatment 
Hyperinsulinaemia is a condition in which there is excess level of insulin circulating in blood than 
expected relative to the level of glucose. Hyperinsulinemia can be seen in a variety of conditions such as pre-
diabetic state and type 2 diabetes mellitus. It is associated with hypertension, obesity, dyslipidaemia and 
abnormal Oral Glucose Tolerance Test (metabolic syndrome). Insulin resistance occurs in type 2 DM. The 
slower and smaller rise in glucose in response to Moringa oleifera seed ingestion suggest that it may indirectly 
play a role in antihyperlipedemic effect and as hypoglycaemic agent, thereby curbing risk of lipid-abnormality 
related diseases such as stroke, coronary heart diseases etc.  
 
Conclusion  
The slowing down of the rate of surge in blood glucose level by Moringa oleifera seed and the reduction of the 
optimal glucose level attainable may be beneficial in reducing insulin resistance and all its attendant bad effects. 
Consumption of Moringa oleifera seed as food supplement may be useful in controlling blood glucose level and 
thus the management of diabetes mellitus. 
 
References 
Duke JA (1997). Moringaceae: Horseradish-tree, benolive-tree, drumstick-tree, Sohnja, Moringa, Murunga, 
Malunggay, p. 19-18. In: M. Benge(ed.) Moringa: A multipurpose vegetable and tree that purifies 
water. Sci & Technol,/ For., Environ., & Natural Resources Agro-Forestation Tech. Ser.. US AID, 
Washington DC. 
Mossa JS (1995). The study on crude antidiabetic drugs use in Arabian folk medicine. International Journal of 
Crude Drug Research 23(3): 137-145 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.17, 2015 
 
7 
Makonnen E, A Hunde, G Damecha (1997). Hypoglycaemic  effect of Moringa stenopetala aqueous extract in 
rabbits. Physiotherapy Research 11:147-148 
Ajibade TO, Arowolo R, Olayemi FO (2013). Phytochemical Screening and Toxicity Studies on Methanolic 
Extract of the Seeds of Moringa oleifera. J complement  Intgr  Med 7;10 pii 
Simonson DC (2015). Surrogate measures of Insulin resistance: does one size fit all? Diabetogia. 58(2) Feb, 207-
10. 
Mehta LK, R Balaraman, AH Amin, PA Bafna, OD Gulati (2003). Effect of the fruit of Moringa oleifera on the 
lipid profile of normal and hypercholesterolaemic rabbits. Journal of Ethnopharmacology 86:191-195 
 
 
The IISTE is a pioneer in the Open-Access hosting service and academic event management.  
The aim of the firm is Accelerating Global Knowledge Sharing. 
 
More information about the firm can be found on the homepage:  
http://www.iiste.org 
 
CALL FOR JOURNAL PAPERS 
There are more than 30 peer-reviewed academic journals hosted under the hosting platform.   
Prospective authors of journals can find the submission instruction on the following 
page: http://www.iiste.org/journals/  All the journals articles are available online to the 
readers all over the world without financial, legal, or technical barriers other than those 
inseparable from gaining access to the internet itself.  Paper version of the journals is also 
available upon request of readers and authors.  
 
MORE RESOURCES 
Book publication information: http://www.iiste.org/book/ 
Academic conference: http://www.iiste.org/conference/upcoming-conferences-call-for-paper/  
 
IISTE Knowledge Sharing Partners 
EBSCO, Index Copernicus, Ulrich's Periodicals Directory, JournalTOCS, PKP Open 
Archives Harvester, Bielefeld Academic Search Engine, Elektronische Zeitschriftenbibliothek 
EZB, Open J-Gate, OCLC WorldCat, Universe Digtial Library , NewJour, Google Scholar 
 
 
